BBI Solutions Overview
- Year Founded
-
1986
- Status
-
Private
- Employees
-
343
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
7
- Investments
-
9
BBI Solutions General Information
Description
Developer and manufacturer of immunoassay and diagnostic products for the diagnostic, healthcare, research, defense and food industries. The company offers technologies for rapid sampling and identification of biothreats and explosives, women's health, energy and digestive products with a portfolio of products and services that include gold reagents, antibodies, antigens, enzymes, serum and plasma, cell culture reagents as well as antibody development services, mobile diagnostic solutions and lateral flow assay development.
Contact Information
Website
www.bbisolutions.comCorporate Office
- Unit 2, Parkway
- Pen-y-fan Industrial Estate
- Crumlin NP11 3EF
- Wales, United Kingdom
Corporate Office
- Unit 2, Parkway
- Pen-y-fan Industrial Estate
- Crumlin NP11 3EF
- Wales, United Kingdom
BBI Solutions Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BBI Solutions Comparisons
Industry
Financing
Details
BBI Solutions Competitors (16)
One of BBI Solutions’s 16 competitors is ProMab Biotechnologies, a Corporate Backed or Acquired company based in Richmond, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ProMab Biotechnologies | Corporate Backed or Acquired | Richmond, CA | ||||
| Creative Diagnostics | Corporation | Shirley, NY | ||||
| GenScript | Formerly VC-backed | Piscataway, NJ | ||||
| ARVYS Proteins | Corporation | Trumbull, CT | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom |
BBI Solutions Patents
BBI Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201714483-D0 | Solid phase conjugate | Inactive | 08-Sep-2016 | ||
| GB-201615233-D0 | Solid phase conjugate | Inactive | 08-Sep-2016 | ||
| GB-2559638-A | Solid phase conjugate | Inactive | 08-Sep-2016 | ||
| US-20190376957-A1 | Solid phase conjugate | Inactive | 08-Sep-2016 | ||
| EP-2214684-A1 | Vaginal lubricant comprising hyaluronic acid | Inactive | 19-Nov-2007 | A61K9/0034 |
BBI Solutions Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BBI Solutions Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BBI Solutions Investments & Acquisitions (9)
BBI Solutions’s most recent deal was a Buyout/LBO with IBEX Pharmaceuticals for . The deal was made on 08-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IBEX Pharmaceuticals | 08-Apr-2024 | Buyout/LBO | Medical Supplies | ||
| BioTeZ | 04-Jan-2022 | Buyout/LBO | Biotechnology | ||
| Diarect | 03-Jun-2020 | Buyout/LBO | Diagnostic Equipment | ||
| Maine Biotechnology Services | 17-Sep-2017 | Buyout/LBO | Biotechnology | ||
| Novarum DX | 10-Oct-2016 | Buyout/LBO | Other Healthcare Technology Systems |
BBI Solutions Exits (3)
BBI Solutions’s most recent exit was on 10-Oct-2016 from Novarum DX. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Novarum DX | 10-Oct-2016 | Completed |
|
||
| Novarum DX | 10-Oct-2016 | Completed |
|
||
| Novarum DX | 19-Jun-2012 | Joint Venture | Completed |
|
BBI Solutions Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Diarect | Freiburg, Germany | 1998 | |
| Theratase | London, United Kingdom | 1993 | |
| Maine Biotechnology Services | Portland, ME | 1990 | |
| IBEX Pharmaceuticals | Montreal, Canada | 1972 | |
| Technologies Ibex | Mont-Royal, Canada | 1972 |
BBI Solutions FAQs
-
When was BBI Solutions founded?
BBI Solutions was founded in 1986.
-
Where is BBI Solutions headquartered?
BBI Solutions is headquartered in Crumlin, United Kingdom.
-
What is the size of BBI Solutions?
BBI Solutions has 343 total employees.
-
What industry is BBI Solutions in?
BBI Solutions’s primary industry is Biotechnology.
-
Is BBI Solutions a private or public company?
BBI Solutions is a Private company.
-
What is BBI Solutions’s current revenue?
The current revenue for BBI Solutions is .
-
How much funding has BBI Solutions raised over time?
BBI Solutions has raised $108M.
-
Who are BBI Solutions’s investors?
Novo Holdings has invested in BBI Solutions.
-
Who are BBI Solutions’s competitors?
ProMab Biotechnologies, Creative Diagnostics, GenScript, ARVYS Proteins, and Abcam are some of the 16 competitors of BBI Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
